This new technology is based on infrared spectroscopy of blood serum (IR-DS). An IR-DS test result allows a clinician to evaluate the biochemical composition of blood serum to diagnose disease conditions within the human body. This technology allows for the detection of many diseases, including cancer, at their earliest stages, in the following organs:

·         stomach

·         large intestine

·         kidneys

·         urinary bladder

·         breasts

·         female reproductive organs

·         prostate gland

·         lymphatic system

·         lungs 

The results from IR-DS testing have: sensitivity 81-93% at specificity 95-100%, diagnostic accuracy for specific disease conditions of between 86% and 93%. If you would like more information about this exciting new diagnostic technology and be interested in partnering with VSA, then please contact me at the telephone number or email address provided below.  VSA will be glad to provide you with as much additional information as you would like. VSA only requests that your company be willing to execute a Non-Disclosure Agreement as to any proprietary information which it may request. VSA looks forward to hearing from you.

Sincerely, 

Sergey VorontsovPresident, VSA American International, Inc. 

`913-568-1258 Direct Line; E-mail: s.vorontsov@vsaai.com